JULENA ADAMS: Open Payments
NPI 1669533295 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,068 in 135 payments from 23 companies in 2025. Trend: 2023 $2,276 · 2024 $2,609 · 2025 $3,068
Food & beverage: $2,780Education: $287
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $745 |
| ABBVIE INC. | 17 | $328 |
| GENZYME CORPORATION | 10 | $270 |
| Regeneron Healthcare Solutions, Inc. | 10 | $207 |
| Amgen Inc. | 12 | $182 |
| Lilly USA, LLC | 10 | $178 |
| Arcutis Biotherapeutics, Inc. | 12 | $171 |
| E.R. Squibb & Sons, L.L.C. | 12 | $165 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| UCB, Inc. | 4 | $96 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, OTEZLA, TALTZ, Zoryve, Sotyktu, Bimzelx.
Industry payments across KY — which companies pay providers there.
